Microarray synthesis and assembly of gene-length polynucleotides
First Claim
Patent Images
1. A process for creating a mixture of double-stranded fragments in solution, the process comprising:
- a) predetermining a target polynucleotide sequence;
b) providing a plurality of single-stranded oligonucleotides bound on a solid or porous surface, wherein each single-stranded oligonucleotide comprise a fragment of the predetermined target polynucleotide sequence, and a flanking sequence, wherein the flanking sequence comprises a primer binding site and a restriction enzyme site permitting removal of the primer binding site, andwherein each single-stranded oligonucleotide is bound to the surface via a cleavable linker moiety;
c) providing a plurality of complementary oligonucleotides, wherein each oligonucleotide of the plurality of complementary oligonucleotide is complementary to the flanking sequence;
d) hybridizing the plurality of said single-stranded oligonucleotides to the plurality of complementary oligonucleotides;
e) extending the hybridized plurality of complementary oligonucleotides to form double-stranded fragments; and
f) cleaving each oligonucleotides at the cleavable linker moiety to form a mixture of double-stranded fragments,wherein the mixture of double-stranded fragments together comprise the predetermined target polynucleotide sequence.
2 Assignments
0 Petitions
Accused Products
Abstract
There is disclosed a process for in vitro synthesis and assembly of long, gene-length polynucleotides based upon assembly of multiple shorter oligonucleotides synthesized in situ on a microarray platform. Specifically, there is disclosed a process for in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, “on device” assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments.
225 Citations
6 Claims
-
1. A process for creating a mixture of double-stranded fragments in solution, the process comprising:
-
a) predetermining a target polynucleotide sequence; b) providing a plurality of single-stranded oligonucleotides bound on a solid or porous surface, wherein each single-stranded oligonucleotide comprise a fragment of the predetermined target polynucleotide sequence, and a flanking sequence, wherein the flanking sequence comprises a primer binding site and a restriction enzyme site permitting removal of the primer binding site, and wherein each single-stranded oligonucleotide is bound to the surface via a cleavable linker moiety; c) providing a plurality of complementary oligonucleotides, wherein each oligonucleotide of the plurality of complementary oligonucleotide is complementary to the flanking sequence; d) hybridizing the plurality of said single-stranded oligonucleotides to the plurality of complementary oligonucleotides; e) extending the hybridized plurality of complementary oligonucleotides to form double-stranded fragments; and f) cleaving each oligonucleotides at the cleavable linker moiety to form a mixture of double-stranded fragments, wherein the mixture of double-stranded fragments together comprise the predetermined target polynucleotide sequence. - View Dependent Claims (2, 3, 4, 5, 6)
-
Specification